STOCK TITAN
  1. Home
  2. CBBT

Cerebain Biotech (CBBT) Stock Price, News & Analysis

CBBT OTC

Company Description

Cerebain Biotech (OTC: CBBT) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for CBBT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
140.2M
Shares outstanding

Latest News

View All
—

Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC

—

Cerebain Biotech Closes Share Exchange Agreement With PKG, Inc.

—

Cerebain Biotech Provides Update on Share Exchange Agreement With PKG, Inc.

Cerebain Biotech has 3 recent news articles. View all CBBT news →

SEC Filings

View All

No SEC filings available for CBBT.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CBBT Company Profile & Sector Positioning

Cerebain Biotech (CBBT) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.